Search Results - "Foucher, Christelle"
-
1
Effect of Fenofibrate on Kidney Function: A 6-Week Randomized Crossover Trial in Healthy People
Published in American journal of kidney diseases (01-06-2008)“…Background Fenofibrate was associated with increases in serum creatinine concentrations. The effect of short-term fenofibrate treatment on kidney function was…”
Get full text
Journal Article -
2
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS)
Published in American journal of kidney diseases (01-03-2005)“…Background: Microalbuminuria is an early marker of diabetic nephropathy and an independent risk factor for cardiovascular disease. In the Diabetes…”
Get full text
Journal Article -
3
Fenofibrate, homocysteine and renal function
Published in Current vascular pharmacology (01-09-2010)“…Fibrates or PPAR alpha agonists, in particular fenofibrate, are known to increase homocysteine levels (Hcy). A 3 to 5 micromol/L increase in Hcy is commonly…”
Get more information
Journal Article -
4
Fibrates and statins in the treatment of diabetic retinopathy
Published in Current pharmaceutical biotechnology (01-03-2011)“…Diabetic retinopathy (DR) is one of the leading risk factors and causes of blindness worldwide. Tight glucose and blood pressure control has been shown to…”
Get more information
Journal Article -
5
Fenofibrate causes elevation of betaine excretion but not excretion of other osmolytes by healthy adults
Published in Journal of clinical lipidology (01-07-2014)“…Background Cross-sectional data suggest that bezafibrate increases betaine excretion in dyslipidemic patients. Objective We aimed to demonstrate that…”
Get full text
Journal Article -
6
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study
Published in The lancet. Diabetes & endocrinology (01-04-2018)“…Gout is a painful disorder and is common in type 2 diabetes. Fenofibrate lowers uric acid and reduces gout attacks in small, short-term studies. Whether…”
Get full text
Journal Article -
7
Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease : The Diabetes Atherosclerosis Intervention Study (DAIS)
Published in Circulation (New York, N.Y.) (08-04-2003)“…The Diabetes Atherosclerosis Intervention Study showed that treatment with fenofibrate decreases progression of coronary atherosclerosis in subjects with type…”
Get full text
Journal Article -
8
New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies
Published in Cardiovascular therapeutics (01-12-2015)“…Guidelines propose additional therapy to statin to treat elevated triglycerides (TG) and low high-density lipoprotein cholesterol (HDLC) in dyslipidemic…”
Get more information
Journal Article -
9
Effect of fenofibrate treatment on the low molecular weight urinary proteome of healthy volunteers
Published in Proteomics. Clinical applications (01-04-2011)“…Purpose: Urinary peptidome changes and discrimination for potential renal glomerular and tubular damage after 6 wk of fenofibrate treatment were evaluated in…”
Get full text
Journal Article -
10
Micronized fenofibrate normalizes the enhanced lipidemic response to a fat load in patients with type 2 diabetes and optimal glucose control
Published in Atherosclerosis (2003)“…This study evaluated the postprandial (PP) response to an oral fat load in 28 male patients with type 2 diabetes (mean HbA1c of 5.1%), all receiving metformin…”
Get full text
Journal Article -
11
Liver microsomal membrane fluidity and microsomal desaturase activities in adult spontaneously hypertensive rats
Published in Journal of hypertension (01-08-1997)“…OBJECTIVEThe purpose of the present study was to investigate liver microsomal membrane fluidity simultaneously with membrane fatty acid composition and…”
Get full text
Journal Article -
12
Alterations of Lipoprotein Fluidity by Non‐Esterified Fatty Acids Known to Affect Cholesteryl Ester Transfer Protein Activity
Published in European journal of biochemistry (01-03-1996)“…The aim of the present study was to investigate the effect of saturated, monounsaturated and polyun‐saturated non‐esterified fatty acids (NEFA) on lipoprotein…”
Get full text
Journal Article -
13
Alterations of lipoprotein fluidity by non-esterified fatty acids known to affect cholesteryl ester transfer protein activity. An electron spin resonance study
Published in European journal of biochemistry (01-03-1996)“…The aim of the present study was to investigate the effect of saturated, monounsaturated and polyunsaturated non-esterified fatty acids (NEFA) on lipoprotein…”
Get full text
Journal Article -
14
Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes
Published in Pharmacogenetics (London) (01-12-2004)“…The association between polymorphisms in candidate genes related to lipoprotein metabolism and the reduction in plasma triglyceride (TG) in response to…”
Get full text
Journal Article